Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,006,345
-$332,802 QoQ
Shares Held
83,320
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#962
of 2,821 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Farmers National Bank holds $29,011,578 across 8 Drug Manufacturers - General names. PFE ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,294 | $14,804,926 | |
| 2 | LLY |
ELI LILLY & Co
|
4,087 | $4,902,070 | |
| 3 | ABBV |
AbbVie Inc.
|
13,102 | $3,296,987 | |
| 4 | PFE |
Pfizer Inc
This page
|
83,320 | $2,006,345 | |
| 5 | AMGN |
Amgen Inc
|
5,193 | $1,880,488 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,329 | $1,198,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,167 | $585,822 | |
| 8 | NVS |
Novartis AG
|
2,145 | $336,164 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,006,345 | 83,320 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,339,147 | 83,303 | Shares | Defined | 2026-06-08 | |
| 2025-12-31 | $2,035,748 | 81,757 | Shares | Defined | 2026-03-12 | |
| 2025-09-30 | $2,260,686 | 88,724 | Shares | Defined | 2025-12-15 | |
| 2025-06-30 | $2,186,859 | 90,217 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,324,792 | 91,744 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,396,931 | 90,348 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,867,165 | 102,472 | Shares | Defined | 2024-08-28 | |
| 2024-03-31 | $2,913,971 | 105,008 | Shares | Defined | 2024-08-28 | |
| 2023-12-31 | $3,280,073 | 113,931 | Shares | Defined | 2024-08-28 | |
| 2023-09-30 | $4,173,349 | 125,817 | Shares | Defined | 2024-08-28 | |
| 2023-06-30 | $4,564,641 | 124,445 | Shares | Sole | 2024-08-28 | |
| 2023-03-31 | $5,131,496 | 125,772 | Shares | Defined | 2024-08-28 | |
| 2022-12-31 | $6,480,475 | 126,473 | Shares | Defined | 2024-08-28 | |
| 2022-09-30 | $5,614,582 | 128,304 | Shares | Defined | 2024-08-28 | |
| 2022-06-30 | $6,808,297 | 129,855 | Shares | Defined | 2024-08-28 | |
| 2022-03-31 | $7,176,149 | 138,616 | Shares | Defined | 2024-08-28 | |
| 2021-12-31 | $8,216,039 | 139,137 | Shares | Defined | 2024-08-28 | |
| 2021-09-30 | $6,530,552 | 151,838 | Shares | Defined | 2024-08-28 | |
| 2021-06-30 | $6,051,158 | 154,524 | Shares | Defined | 2024-08-28 | |
| 2021-03-31 | $5,160,926 | 142,449 | Shares | Defined | 2024-08-28 | |
| 2020-12-31 | $5,589,155 | 151,838 | Shares | Defined | 2024-08-28 | |
| No filing history on record for this holder in this stock. | ||||||